Scarica l'app Stockscreener
0.3001
15.38%
0.04
Dopo l'orario di chiusura:
.29
-0.0101
-3.37%
Sangamo Therapeutics Inc Azioni (SGMO) Dati Finanziari
Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
| Data di fine periodo | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
| Durata del periodo | 3 mesi | 3 mesi | 3 mesi | 3 mesi | 3 mesi |
| Revenues |
96.83%
0.581
|
18.31 | 6.437 | 7.551 | 49.41 |
Operating Expenses
|
0.07%
36.13
|
36.16 | 36.06 | 33.54 | 38.78 |
| Benefits Costs and Expenses |
6.78%
35.67
|
38.27 | 36.91 | 31.37 | 38.65 |
| Costs And Expenses |
6.78%
35.67
|
38.27 | 36.91 | 31.37 | 38.65 |
| Operating Income/Loss |
99.12%
-35.55
|
-17.86 | -29.63 | -25.99 | 10.63 |
| Income/Loss From Continuing Operations Before Tax |
75.82%
-35.09
|
-19.96 | -30.48 | -23.82 | 10.76 |
| Income Tax Expense/Benefit |
696.30%
-0.161
|
0.027 | 0.119 | -0.427 | 0.088 |
| Income/Loss From Continuing Operations After Tax |
74.77%
-34.93
|
-19.99 | -30.60 | -23.40 | 10.67 |
|
Net Income/Loss
|
74.77%
-34.93
|
-19.99 | -30.60 | -23.40 | 10.67 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | 1.287 |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
18.42%
304.27
|
256.95 | 220.27 | 2.85 | 208.34 |
| Diluted Average Shares |
18.42%
304.27
|
256.95 | 220.27 | 2.85 | 214.32 |
| Basic Earnings Per Share |
37.50%
-0.11
|
-0.08 | -0.14 | -0.12 | 0.05 |
| Diluted Earnings Per Share |
37.50%
-0.11
|
-0.08 | -0.14 | -0.12 | 0.04 |
| Undistributed Earnings/Loss Allocated To Participating Securities, Basic |
-
|
- | - | - | 1.287 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | 2.574 |
0.49%
1.47%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):